Sorry, we couldn't find any posts. Please try a different search.

“Leaving The Ivory Tower – From Lab To Wall Street”, 10/22, University Of Montana – Missoula

“Given that I am at the crossroads of biomedical academic research and the capital markets, I think my presentation will add an interesting dimension and new outlook for many scientists, teachers, researchers, administrators and students,” Jasuja said.

Stanford researcher defends stem cell work in Hamilton, Montana lecture

“They’re perfectly right to have that opinion,” Weissman said. “They’re not right to impose it on the rest of us.”

LigoCyte, Biogen Idec to jointly develop anti-inflammatory treatment

LigoCyte Pharmaceuticals Inc said it and biotechnology group Biogen Idec Inc have agreed to jointly develop anti-inflammatory drugs.

"Global Infectious Disease, Environment And Human Health", 9/29, Big Sky, Montana

The talk is being given in conjunction with the second annual Northern Rocky Mountain Conference on Infectious Disease and Environmental Health co-sponsored by the INBRE and COBRE programs at Montana State University.

“Stem Cell Research: Daring To Dream” Dr. Irving Weissman, 9/18, Hamilton, MT

Weissman is considered one of the world’s foremost experts in the fields of immunology, developmental biology and stem cells.

Montana Department of Commerce to Provide $2 Million for Bio-Medical Research

"Montana has unlimited research opportunities," said Governor Brian
Schweitzer. "We have groundbreaking research taking place every day
across Montana. This funding will foster continued development in our
growing technology sector and allow Montana to remain competitive in the
world of bio-research."

Rocky Mountain Laboratories research leads to a potential STD vaccine

Research by scientists at RML has recently been honored and recognized by an international biotechnology industry.

Montana BioScience Alliance – July Meeting Is Open To All, 7/2, Great Falls, MT

We are providing the opportunity for everyone interested to join the Scientific Advisory Committee meeting at McLaughlin Research Center in Great Falls on July 2nd and hear and interact with some of the country’s most prestigious scientists and researchers.

The biosafety level 4 facility under construction at Rocky Mountain Laboratories in Hamilton, Montana represents the third phase in the history of RML, Dr. Karl Johnson said Friday.

With the new lab, Johnson said, “the National Institutes of Health finally has a full quiver of facilities; if new things come up, they can make intelligent decisions” about how and where to address them.

Dr. Irving Weissman, Stanford University "Stem Cell Research And The Future", 4/20, Bozeman, MT

Weissman graduated from Montana State College in 1961 and received an honorary doctorate from MSU in 1992. He holds multiple professorships at Stanford University in pathology, developmental biology, neurosurgery and biological sciences.